Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Recurrence
×
ofatumumab
×
Clear all
Filters
3
NCT01578707
2019-12-18
RESONATEâ„¢
Pharmacyclics LLC.
Phase 3
Completed
391 enrolled
14 charts
NCT01014208
2015-08-07
ORCHARRD
GlaxoSmithKline
Phase 3
Completed
447 enrolled
21 charts